Nanotechnology
Researchers co-led by the Institute for Bioengineering of Catalonia (IBEC) and West China Hospital Sichuan University (WCHSU) have made a groundbreaking discovery in treating Alzheimer's disease with a nanotechnology strategy. Unlike traditional nanomedicine, this approach employs bioactive nanoparticles, known as "supramolecular drugs," which restore the proper
Alzheimer's disease
Researchers co-led by the Institute for Bioengineering of Catalonia (IBEC) and West China Hospital Sichuan University (WCHSU) have made a groundbreaking discovery in treating Alzheimer's disease with a nanotechnology strategy. Unlike traditional nanomedicine, this approach employs bioactive nanoparticles, known as "supramolecular drugs," which restore the proper
Alzheimer's disease
A groundbreaking study conducted by researchers at the University of Concepcion in Concepcion, Chile, has shed new light on the early stages of Alzheimer's disease. The researchers found that intracellular accumulation of A beta was higher in neurons of the APP/PS1 mice at 10 and 15 days
